ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q1 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $703,031 | +26.1% | 1,430 | 0.0% | 0.57% | +59.8% |
| Q2 2023 | $557,314 | +4.6% | 1,430 | 0.0% | 0.36% | -1.9% |
| Q1 2023 | $532,789 | +26.7% | 1,430 | +28.8% | 0.36% | +25.2% |
| Q4 2022 | $420,501 | +7.3% | 1,110 | 0.0% | 0.29% | +16.0% |
| Q3 2022 | $392,000 | -6.9% | 1,110 | 0.0% | 0.25% | -13.5% |
| Q2 2022 | $421,000 | +20.3% | 1,110 | 0.0% | 0.29% | +74.1% |
| Q1 2022 | $350,000 | -11.6% | 1,110 | -1.8% | 0.17% | +41.9% |
| Q4 2021 | $396,000 | – | 1,130 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |